A- Student of B. Pharmacy Mahatma Gandhi College of Pharmaceutical Sciences, Jaipur, Rajasthan, India
C Assistant Professor Mahatma Gandhi College of Pharmaceutical Sciences, Jaipur, Rajasthan, India
Corresponding author: sauravsuryavanshi81@gmail.com
Abstract Conference Pics
Parkinson's disease (PD) is a disease characterized and primarily diagnosed by its physical manifestations. The symptoms, such as bradykinesia and muscle rigidity, are mediated by loss of dopaminergic neurons in the brain. One major obstacle with PD is that once symptoms are apparent and the disease can be properly diagnosed, the loss of dopaminergic neurons is already severe and any chance for intervention is not possible. Early detection and treatment of PD are the goals of current research for this disease. This review delves into the current state of research into biomarkers for PD as well as possible future treatment targets for the disease and their plausibility. Biomarker: Signs and symptoms present many years before the disease is clinically diagnosable. Biomarkers are of interest due to their potential to be used to guide therapy. Certain biomarkers are more reliable than others. Biomarkers with a limited number of studies including restless leg syndrome, color vision loss, cognitive impairment, mood and affective disorders . These biomarkers are present in a variety of diseases. They are less specific to Parkinsons Disease. Parkinsons Disease is difficult to diagnose early, but some biomarkers may provide some signs for earlier detection. More research is needed on these biomarkers to make them
No comments:
Post a Comment